The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmaceutical Grade Canthaxanthin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pharmaceutical Grade Canthaxanthin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1759630

No of Pages : 97

Synopsis
The global Pharmaceutical Grade Canthaxanthin market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Canthaxanthin is a carotenoid pigment. Deep purple crystal or crystalline powder. The melting point is about 210°C (decomposition). Oxygen and light instability. It should be stored in a light-shielding container filled with inert gas. Soluble in chloroform (10%), slightly soluble in vegetable oil (0.005%), acetone (0.03%). Insoluble in water, ethanol, propylene glycol. The stable commercial product is in the form of a solution in fat or organic solvent, or in the form of a water-dispersible orange to red powder or granules. After coloring, the color tone is not affected by the pH value, it is also quite stable to sunlight, and it is not easy to fade.
This report is a detailed and comprehensive analysis for global Pharmaceutical Grade Canthaxanthin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical Grade Canthaxanthin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Pharmaceutical Grade Canthaxanthin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Pharmaceutical Grade Canthaxanthin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Pharmaceutical Grade Canthaxanthin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Grade Canthaxanthin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Grade Canthaxanthin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DSM, Allied Biotech, Divi's Nutraceuticals, Kanvergen and Beijing Chengkun Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pharmaceutical Grade Canthaxanthin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Canthaxanthin 5%
Canthaxanthin 10%
Canthaxanthin 15%
Others
Market segment by Application
Pharmaceutical Production Plant
Laboratory
Others
Major players covered
DSM
Allied Biotech
Divi's Nutraceuticals
Kanvergen
Beijing Chengkun Biotechnology
Zhejiang Medicine
Zhejiang Xinhecheng
Changsha Xuhe Biotechnology
Hebei Runbu Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade Canthaxanthin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade Canthaxanthin, with price, sales, revenue and global market share of Pharmaceutical Grade Canthaxanthin from 2018 to 2023.
Chapter 3, the Pharmaceutical Grade Canthaxanthin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade Canthaxanthin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Grade Canthaxanthin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade Canthaxanthin.
Chapter 14 and 15, to describe Pharmaceutical Grade Canthaxanthin sales channel, distributors, customers, research findings and conclusion.
Index
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Grade Canthaxanthin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pharmaceutical Grade Canthaxanthin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Canthaxanthin 5%
1.3.3 Canthaxanthin 10%
1.3.4 Canthaxanthin 15%
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Pharmaceutical Grade Canthaxanthin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Production Plant
1.4.3 Laboratory
1.4.4 Others
1.5 Global Pharmaceutical Grade Canthaxanthin Market Size & Forecast
1.5.1 Global Pharmaceutical Grade Canthaxanthin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pharmaceutical Grade Canthaxanthin Sales Quantity (2018-2029)
1.5.3 Global Pharmaceutical Grade Canthaxanthin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 DSM
2.1.1 DSM Details
2.1.2 DSM Major Business
2.1.3 DSM Pharmaceutical Grade Canthaxanthin Product and Services
2.1.4 DSM Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 DSM Recent Developments/Updates
2.2 Allied Biotech
2.2.1 Allied Biotech Details
2.2.2 Allied Biotech Major Business
2.2.3 Allied Biotech Pharmaceutical Grade Canthaxanthin Product and Services
2.2.4 Allied Biotech Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Allied Biotech Recent Developments/Updates
2.3 Divi's Nutraceuticals
2.3.1 Divi's Nutraceuticals Details
2.3.2 Divi's Nutraceuticals Major Business
2.3.3 Divi's Nutraceuticals Pharmaceutical Grade Canthaxanthin Product and Services
2.3.4 Divi's Nutraceuticals Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Divi's Nutraceuticals Recent Developments/Updates
2.4 Kanvergen
2.4.1 Kanvergen Details
2.4.2 Kanvergen Major Business
2.4.3 Kanvergen Pharmaceutical Grade Canthaxanthin Product and Services
2.4.4 Kanvergen Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kanvergen Recent Developments/Updates
2.5 Beijing Chengkun Biotechnology
2.5.1 Beijing Chengkun Biotechnology Details
2.5.2 Beijing Chengkun Biotechnology Major Business
2.5.3 Beijing Chengkun Biotechnology Pharmaceutical Grade Canthaxanthin Product and Services
2.5.4 Beijing Chengkun Biotechnology Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Beijing Chengkun Biotechnology Recent Developments/Updates
2.6 Zhejiang Medicine
2.6.1 Zhejiang Medicine Details
2.6.2 Zhejiang Medicine Major Business
2.6.3 Zhejiang Medicine Pharmaceutical Grade Canthaxanthin Product and Services
2.6.4 Zhejiang Medicine Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Zhejiang Medicine Recent Developments/Updates
2.7 Zhejiang Xinhecheng
2.7.1 Zhejiang Xinhecheng Details
2.7.2 Zhejiang Xinhecheng Major Business
2.7.3 Zhejiang Xinhecheng Pharmaceutical Grade Canthaxanthin Product and Services
2.7.4 Zhejiang Xinhecheng Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zhejiang Xinhecheng Recent Developments/Updates
2.8 Changsha Xuhe Biotechnology
2.8.1 Changsha Xuhe Biotechnology Details
2.8.2 Changsha Xuhe Biotechnology Major Business
2.8.3 Changsha Xuhe Biotechnology Pharmaceutical Grade Canthaxanthin Product and Services
2.8.4 Changsha Xuhe Biotechnology Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Changsha Xuhe Biotechnology Recent Developments/Updates
2.9 Hebei Runbu Biotechnology
2.9.1 Hebei Runbu Biotechnology Details
2.9.2 Hebei Runbu Biotechnology Major Business
2.9.3 Hebei Runbu Biotechnology Pharmaceutical Grade Canthaxanthin Product and Services
2.9.4 Hebei Runbu Biotechnology Pharmaceutical Grade Canthaxanthin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hebei Runbu Biotechnology Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Grade Canthaxanthin by Manufacturer
3.1 Global Pharmaceutical Grade Canthaxanthin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pharmaceutical Grade Canthaxanthin Revenue by Manufacturer (2018-2023)
3.3 Global Pharmaceutical Grade Canthaxanthin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pharmaceutical Grade Canthaxanthin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pharmaceutical Grade Canthaxanthin Manufacturer Market Share in 2022
3.4.2 Top 6 Pharmaceutical Grade Canthaxanthin Manufacturer Market Share in 2022
3.5 Pharmaceutical Grade Canthaxanthin Market: Overall Company Footprint Analysis
3.5.1 Pharmaceutical Grade Canthaxanthin Market: Region Footprint
3.5.2 Pharmaceutical Grade Canthaxanthin Market: Company Product Type Footprint
3.5.3 Pharmaceutical Grade Canthaxanthin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pharmaceutical Grade Canthaxanthin Market Size by Region
4.1.1 Global Pharmaceutical Grade Canthaxanthin Sales Quantity by Region (2018-2029)
4.1.2 Global Pharmaceutical Grade Canthaxanthin Consumption Value by Region (2018-2029)
4.1.3 Global Pharmaceutical Grade Canthaxanthin Average Price by Region (2018-2029)
4.2 North America Pharmaceutical Grade Canthaxanthin Consumption Value (2018-2029)
4.3 Europe Pharmaceutical Grade Canthaxanthin Consumption Value (2018-2029)
4.4 Asia-Pacific Pharmaceutical Grade Canthaxanthin Consumption Value (2018-2029)
4.5 South America Pharmaceutical Grade Canthaxanthin Consumption Value (2018-2029)
4.6 Middle East and Africa Pharmaceutical Grade Canthaxanthin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pharmaceutical Grade Canthaxanthin Sales Quantity by Type (2018-2029)
5.2 Global Pharmaceutical Grade Canthaxanthin Consumption Value by Type (2018-2029)
5.3 Global Pharmaceutical Grade Canthaxanthin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pharmaceutical Grade Canthaxanthin Sales Quantity by Application (2018-2029)
6.2 Global Pharmaceutical Grade Canthaxanthin Consumption Value by Application (2018-2029)
6.3 Global Pharmaceutical Grade Canthaxanthin Average Price by Application (2018-2029)
7 North America
7.1 North America Pharmaceutical Grade Canthaxanthin Sales Quantity by Type (2018-2029)
7.2 North America Pharmaceutical Grade Canthaxanthin Sales Quantity by Application (2018-2029)
7.3 North America Pharmaceutical Grade Canthaxanthin Market Size by Country
7.3.1 North America Pharmaceutical Grade Canthaxanthin Sales Quantity by Country (2018-2029)
7.3.2 North America Pharmaceutical Grade Canthaxanthin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pharmaceutical Grade Canthaxanthin Sales Quantity by Type (2018-2029)
8.2 Europe Pharmaceutical Grade Canthaxanthin Sales Quantity by Application (2018-2029)
8.3 Europe Pharmaceutical Grade Canthaxanthin Market Size by Country
8.3.1 Europe Pharmaceutical Grade Canthaxanthin Sales Quantity by Country (2018-2029)
8.3.2 Europe Pharmaceutical Grade Canthaxanthin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pharmaceutical Grade Canthaxanthin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pharmaceutical Grade Canthaxanthin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pharmaceutical Grade Canthaxanthin Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Grade Canthaxanthin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pharmaceutical Grade Canthaxanthin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pharmaceutical Grade Canthaxanthin Sales Quantity by Type (2018-2029)
10.2 South America Pharmaceutical Grade Canthaxanthin Sales Quantity by Application (2018-2029)
10.3 South America Pharmaceutical Grade Canthaxanthin Market Size by Country
10.3.1 South America Pharmaceutical Grade Canthaxanthin Sales Quantity by Country (2018-2029)
10.3.2 South America Pharmaceutical Grade Canthaxanthin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pharmaceutical Grade Canthaxanthin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pharmaceutical Grade Canthaxanthin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pharmaceutical Grade Canthaxanthin Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Grade Canthaxanthin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pharmaceutical Grade Canthaxanthin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pharmaceutical Grade Canthaxanthin Market Drivers
12.2 Pharmaceutical Grade Canthaxanthin Market Restraints
12.3 Pharmaceutical Grade Canthaxanthin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pharmaceutical Grade Canthaxanthin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Grade Canthaxanthin
13.3 Pharmaceutical Grade Canthaxanthin Production Process
13.4 Pharmaceutical Grade Canthaxanthin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharmaceutical Grade Canthaxanthin Typical Distributors
14.3 Pharmaceutical Grade Canthaxanthin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’